- Home
- WULF vs FOLD Comparison
WULF vs FOLD Comparison
Compare WULF & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WULF
- FOLD
- Stock Information
- Founded
- WULF 1952
- FOLD 2002
- Country
- WULF United States
- FOLD United States
- Employees
- WULF N/A
- FOLD N/A
- Industry
- WULF EDP Services
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- WULF Technology
- FOLD Health Care
- Exchange
- WULF Nasdaq
- FOLD Nasdaq
- Market Cap
- WULF 2.6B
- FOLD 2.9B
- IPO Year
- WULF 1995
- FOLD 2007
- Fundamental
- Price
- WULF $6.40
- FOLD $9.41
- Analyst Decision
- WULF Strong Buy
- FOLD Strong Buy
- Analyst Count
- WULF 9
- FOLD 8
- Target Price
- WULF $7.97
- FOLD $17.00
- AVG Volume (30 Days)
- WULF 32.1M
- FOLD 2.2M
- Earning Date
- WULF 11-12-2024
- FOLD 02-26-2025
- Dividend Yield
- WULF N/A
- FOLD N/A
- EPS Growth
- WULF N/A
- FOLD N/A
- EPS
- WULF N/A
- FOLD N/A
- Revenue
- WULF $128,351,000.00
- FOLD $493,671,000.00
- Revenue This Year
- WULF $110.37
- FOLD $34.33
- Revenue Next Year
- WULF $106.76
- FOLD $21.70
- P/E Ratio
- WULF N/A
- FOLD N/A
- Revenue Growth
- WULF 131.22
- FOLD 32.58
- 52 Week Low
- WULF $1.24
- FOLD $8.79
- 52 Week High
- WULF $9.30
- FOLD $14.03
- Technical
- Relative Strength Index (RSI)
- WULF 51.60
- FOLD 45.88
- Support Level
- WULF $5.82
- FOLD $8.79
- Resistance Level
- WULF $6.33
- FOLD $9.47
- Average True Range (ATR)
- WULF 0.52
- FOLD 0.30
- MACD
- WULF 0.07
- FOLD 0.02
- Stochastic Oscillator
- WULF 84.62
- FOLD 62.00
About WULF TeraWulf Inc.
TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. The company's primary focus is supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. The company's primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.